Our paper is out! Excited to be part of such an amazing team unravelling the complexities of lung tumour/TME coevolution in #TRACERx Big thanks to all those involved in the project and who supported our work. Presented by @CharlesSwanton at #AACR24 Check out our Tweetorial below.
What is the role of the TME in lung cancer evolution? We are excited to share our new TRACERx paper “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer” at #AACR24, out in @CD_AACR today https://t.co/5bWeXqK2I0 Tweetorial👇
A team of researchers led by postdocs @EnfieldKatey, @jboumelha and @KevinWNg found that fragments of ancient viral DNA that can be ‘reawakened’ in cancerous cells are a potential target for cancer immunotherapy treatments.
@JulianDownward | @SwantonLab https://t.co/XnHDWswiDH
Excited to share our TRACERx nature publication on circulating tumor DNA (#ctDNA, #MRD) detection in resectable lung cancer led by @AbboshChris, @Afrankell, @juditkisistok, Thomas Harrison, Aaron Garnett, @nbirkbak and @NickyMcGranahan 👇👇👇 Tweetorial🧵
https://t.co/FqXgH882cf
Our review @WillHilliam@LimEmilia@EvaGronroos@CharlesSwanton is out in this stellar issue of @CellCellPress! We address how our environment can promote tumours from otherwise dormant oncogenic cells and ask "Are these processes preventable?"
https://t.co/fozzidoi8F
Dive into the data behind the landmark #TRACERx study 🔍
📅 Nine years of research
👥 800+ patients
️🧑🔬 250 investigators
🏥 13 hospital sites.
Read more about the study and what it means for future lung cancer patients: https://t.co/TxlTFdSLta
@TheCrick@UCL
Today, @nature and @NatureMedicine are proud to publish amazing new insights into lung cancer evolution from the #TRACERx consortium. Updated collection: https://t.co/MmOQoU47uU Great author threads👇
Cachexia is a devastating condition in patients with cancer. Our study on cancer cachexia in #TRACERx is out today in @NatureMedicine led by @Othman_Al_Sawaf, @MariamJHanjani, @SwantonLab:
https://t.co/HZtXidMTwA
Key results in a brief 🧵
Excited to share our recent @SwantonLab@NickyMcGranahan & @MariamJHanjani lab work on the genomic evolution of non-small cell lung cancer metastases in #TRACERx, out @Nature
https://t.co/bmV9Q0cySW
A quick thread [1/13]
Very excited that our paper on B cells and immunotherapy in lung cancer is out today @Nature . A privilege to work alongside @KevinWNg @EnfieldKatey on this. Give it a read ✨✨
https://t.co/H3vuFM667W
Our paper together with @SwantonLab@CharlesSwanton ‘Genomic-transcriptomic evolution in lung cancer and metastasis’ comes out today @Nature. https://t.co/VIODHRQqu7 Read all about it 🚨👇 1/9
What a privilege to be part of this exciting cross-lab collaboration with outstanding scientists @KevinWNg @jboumelha. All made possible thanks to our talented collaborators, funders, patients, and mentorship from @CharlesSwanton@JulianDownward and George Kassiotis @TheCrick
Excited to share our work finding an unexpected role for tumour-reactive B cells in immunotherapy response in lung cancer, led by @KevinWNg @jboumelha@EnfieldKatey, now published in @nature with @CharlesSwanton and George Kassiotis labs @TheCrick
https://t.co/zUJZdekNLI
Excited to share Refphase- a new R package for identifying haplotype-specific SCNAs and parallel copy number evolution in cancer. bioRXiv- https://t.co/P1BKUXJojh Tool- https://t.co/sNndo4mGaE More below 👇 @tbkwatkins@rfschwarz@MattHuska@CharlesSwanton@NickyMcGranahan 🖥️🧬
Very proud to be a part of the exciting collaborative research featured in the exhibition #OutwittingCancer
You can check it out for free @TheCrick or visit online #WorldCancerDay2022 https://t.co/lkIWBg9f1e
It’s exciting to finally share and discuss our study on additive cytotoxicity, a crowd-based killing mechanism of cytotoxic T cells (CTL) to target cancer!
Highlights in the thread, free access @NatureComms here: https://t.co/i5lTxdJNMN
1/17
#immunology#microscopy